Women who develop infection during delivery hospitalization are at higher risk of being readmitted for ischaemic stroke within 30 days postpartum, especially those with no hypertensive disorders of pregnancy, a study reports.
Measuring the ratio of the soluble fms-like tyrosine kinase 1 (sFlt-1) to placental growth factor (PlGF) improves the accuracy of identifying pre-eclampsia without changing admission rates, according to the results of a trial.
Having identified the prevalence and increased risk of masked hypertension in pregnant women, a recent study suggests that an office blood pressure (BP) of at least 125/75 mm Hg in the second half of gestation may be appropriate to indicate out-of-office measurements in high-risk pregnancies.
Lower age at onset of first menstruation poses an increased risk of type 2 diabetes mellitus (T2DM) later in life, possibly driven by adult body mass index (BMI), whereas later menarche is associated with reduced diabetes risk, a study has found.
Women who have premature ovarian insufficiency and are receiving hormone therapy (HT) appear to have poor sleep quality, taking longer to fall asleep and experiencing greater fatigue, according to a recent study.
Supplemental folate intake appears to mitigate the adverse effect of exposure to raised levels of nitrogen dioxide on the likelihood of a live birth in women undergoing assisted reproductive technologies, according to a study.
Hyperinsulinaemia and insulin resistance appear to exacerbate phenotypic characteristics, reproductive endocrine disorders, and glucose and lipid metabolic dysfunction in polycystic ovary syndrome (PCOS) patients and therefore lead to reduced fertility in these women, a study has found.
Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.
The addition of ezetimibe improves statin treatment in acute coronary syndrome (ACS) patients with dyslipidaemia and low eicosapentaenoic acid-to-arachidonic acid (EPA/AA) ratio, resulting in a lowered risk of cardiovascular events compared to monotherapy, according to a study presented at the recently concluded 2019 Congress of the European Society of Cardiology (ESC 2019) held in Paris, France.